Protective and sensitive effects of melatonin combined with adriamycin on ER+ (estrogen receptor) breast cancer

European Journal of Gynaecological Oncology

Volumn 36, Issue 2, 2015, Pages 197-202

  Ma, C ^a   Li, L X ^a   Zhang, Y ^a   Xiang, C ^a   Ma, T ^a   Ma, Z Q ^a   Zhang, Z P ^a  

^a FIRST HOSPITAL OF SHIJIAZHUANG   (China)

Author keywords

Adriamycin; Breast cancer; Melatonin; Metastasis

Indexed keywords

DOXORUBICIN; ESTROGEN RECEPTOR; MELATONIN; UVOMORULIN; CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER RESISTANCE; CANCER SURVIVAL; CARCINOGENESIS; CARDIOTOXICITY; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ELECTRON MICROSCOPY; FEMALE; GENE EXPRESSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MICROSCOPY; NONHUMAN; QUALITY OF LIFE; RAT; SENSITIVITY ANALYSIS; SURVIVAL RATE; TUMOR CELL; TUMOR VOLUME; ANIMAL; CHEMISTRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MORTALITY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CADHERINS; DOXORUBICIN; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN;

EID: 84929413184     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: 10.12892/cjgo2586.2015     Document Type: Article

References (29)

1. Billingham M.E., Mason J.W., Bristow M.R., Daniels J.R.: "An- Thracycline cardiomyopathy monitored by morphologic changes". Cancer Treat. Rep., 1978, 62, 865.
2. Bristow M.R., Thompson P.D., Martin R.P., Mason J.W. Billingham M.E., Harrison D.C.: "Early anthracycline cardiotoxicity". Am. J. Med., 1978, 65, 823.
3. Rock E., DeMichele A.: "Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors". J. Nutr., 2003, 133, 3785S.
4. Chicco A.J., Schneider C.M., Hayward R.: "Voluntary exercise protects against acute doxorubicin cardiotoxicity in the isolated perfused rat heart". Am. J. Physiol. Regul. Integ. Comp. Physiol., 2005, 289, R424.
5. Chicco AJ., Schneider CM., Hayward R.: "Exercise training attenuates acute doxorubicin-induced cardiac dysfunction". J. Cardiovasc. Phar macol., 2006, 47, 182.
6. Hydock D.S., Lien C.Y., Schneider C.M., Hayward R.: "Exercise preconditioning protects against doxorubicin-induced cardiac dysfunction". Med. Sci. Sports Exerc., 2008, 40, 808.
7. Albini A., Pennesi G., Donatelli F., Cammarota R., De Flora S., Noonan DM.: "Cardiotoxicity of anticancer drugs: The need for cardio-on- cology and cardio-oncologica] prevention". J. Natl. Cancer. Inst., 2010, 102, 14.
8. Sanchez-Barceló E.J., Cos S., Mediavilla D., Martinez-Campa C., Gonzalez A., Alonso-Gonzalez C.: "Melatonin-estrogen interactions in breast cancer". J. Pineal Res., 2005, 38, 217.
9. Jawed S., Kim B., OttenhofT., Brown GM., Werstiuk E.S., Niles L.P.: "Human melatonin MT1 receptor induction by valproic acid and its effects in combination with melatonin on MCF-7 breast cancer cell proliferation". Eur. J. Pharmacol., 2007, 560, 17.
10. Lissoni P.: "Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pin eal agent". Pathol. Biol., 2007, 55, 198.
11. Martinez-Campa C., Gonzalez A., Mediavilla M.D., Alonso-Gonzalez C., Alvarez-Garcia V., Sanchez-Barcelo E.J., et al.: "Melatonin inhibits aromatase promoter expression by regulating clooxygenases expression and activity in breast cancer cells". Br. J. Cancer., 2009, 101, 1613.
12. Zhang Y., Zhu S., Liu J.: "The reverse effect and mechanism of melatonin on breast carcinoma cell line MCF-7/ADM resistant to Adriamycin". Chinese Journal of Clinical Oncology, 2009, 36, 291.
13. Zhang Y., Zhu S., Zhao W.: "The effect of melatonin on the sensitivity of ER+ breast carcinoma cell line MCF-7 to Adriamycin and its mechanism". Chinese Journal of Clinical Oncology, 2009, 36, 1243.
14. Orendas P., Kassayova M., Kajo K., Ahlers I., Kubatka P., Bojkova B., et al.: "Celecoxib and melatonin in prevention of female rat mammary carcinogenesis". Neoplasma, 2009, 56, 252.
15. Wei W., Shen YX., Dai M., Chen Q.: "Effects and mechanisms of melatonin on immune responses in mice of different months". Acta Pharmacol. Sin., 2003, 24, 719.
16. Esquifinoa A.I., Pandi-Perumalb S.R., Cardinali D.P.: "Orcadian organization of the immune response: A role for melatonin". Clinical and Applied Immunology Reviews, 2004, 4, 423.
17. Leon-Blanco M.M., Guerrero JM., Reiter R.J., Pozo D.: "RNA expression of human telomerase subunits TR and TERT is differentially affected by melatonin receptor agonists in the MCF-7 tumor cell line". Cancer Lett., 2004, 216, 73.
18. Mirunalini S., Karthishwaran K., Dhamodharan G., Shalini M.: "Melatonin attenuates lipid peroxidation and enhances circulatory antioxidants during mammary carcinogenesis in rats". J. Biochem. Tech., 2010, 2, 171.
19. Lissoni P.: "Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms". Pathologie Biologie, 2007, 55, 201.
20. Miller S.C., Pandi P.S., Esquifino A.I., Cardinali D.P., Maestroni G.J.: "The role of melatonin in immounoenhancement: potential application in cancer". Int. J. Exp. Pathol., 2006, 57, 81.
21. Srinivasn V., Spence D.W., Pandi-Perumal S.R.: "Therapeutic actions of melatonin in cancer: possible mechanisms". Integr. Cancer Then, 2008, 7, 189.
22. Bruck R., Aeed H., Avni Y., Shirin H., Matas Z., Shahmurov M., et al.: "Melatonin inhibits nuclear factor kappa B activation and ox- idativestress and protects against thioacetamide induced liver damage in rats". J. Hepatol, 2004, 40, 86.
23. Ganguly K., Kundu P., Baneijee A., Reiter RJ., Swamakar S.: "Hydrogen Peroxidemediated downregulation of mat rix metalloprotease-2 in indomet hacininduced acute gastric ulceration is blocked by melatonin and other antioxidants". Free Radic Biol. Med., 2006, 41, 911.
24. Kiarostami V., Samini L., Chazi-Khansari M.: "Protective effect of melatonin against multistress condition induced lipid peroxidation via measurement of gastric mucosal lesion and plasma malondi- Aldehyde levels in rats". World J. Gastroenterol., 2006, 12, 7527.
25. Tamura H., Takasaki A., Miwa I., Taniguchi K., Maekawa R., Asada H., et al.: "Oxidative stress impairs oocyte quality and melatonin protects oocytes from free randical damage and improves fertilization rate". J. Pineal Res., 2008, 44, 280.
26. Zhang Y., Li L.X., Xiang C., Ma Z., Ma T., Zhu S.: "Protective effect of melatonin against Adriamycin-induced cardiotoxicity". Exp. Ther. Med., 2013, 5, 1496.
27. Cos S., Fernandez R.: "Melatonin effects on intercellular junctional communication in MCF-7 human breast cancer cells". Pineal Res., 2000, 29, 166.
28. Garcia Pedrero J.M., Del Rio B., Martinez-Campa C., Muramatsu M., Lazo P.S., Ramos S.: "Calmodulin is a selective modulator of estrogen receptors". Mol. Endocrinol., 2002, 16, 947.
29. Yurtcu E., Guney Y., Ergun M.A., Guney H.Z., Uluoglu C., Hicsonmez A., et al.: "Lack of a time-dependent effect of melatonin on radiation-induced apoptosis in cultured rat lymphocytes". Cell Biology International, 2007, 31, 1144.